The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.

Share:
More In Business
What's to Come for the 'Magnificent 7'
Matt Stucky, Chief Portfolio Manager of Equities at Northwestern Mutual Wealth Management chats why Nvidia has been unsteady leading up to its latest earnings results, plus what’s to come for the so-called ‘Magnificent 7.’
Load More